
What’s Driving the Boom in Early Stage Biotech Funding?
The LabTech website noted that J&J Innovation is one of the many investors that are turning their gaze to the promise of early-stage research. J&J Innovation is following a strategy focusing on supporting ‘open innovation’, an approach that they believe could work where the traditional pharma approach has failed. J&J entered a collaboration
Comments Off on What’s Driving the Boom in Early Stage Biotech Funding? • Read this story »
More Articles

Open Innovation: The Strongest Catalyzing Force in Healthcare
The InVenture website reported that Open Innovation, the power of collaboration between startups and larger organizations, will be a key theme at this year’s Health.Pioneers conference in Vienna on October 10. With Open Innovation at the heart of the event’s philosophy, Health.Pioneers is bringing
Comments Off on Open Innovation: The Strongest Catalyzing Force in Healthcare • Read this story »

Novozymes and Grundfos Kick off Collaboration for Clean Water
The Sustainable Brands website noted that when you combine biotech with cutting-edge water technology, you might find new solutions to some of the most pressing global issues concerning water scarcity. This is the scope, when the world’s leading expert in enzymes and microorganisms, Novozymes, and
Comments Off on Novozymes and Grundfos Kick off Collaboration for Clean Water • Read this story »